🟢 Stem is trading 5% up; catalyst remains unclear

Stem is trading 5.08% higher at $2.69, with no confirmed catalyst identified for the gain.

• The strategic-alternatives review, including a possible sale or merger, was announced October 26 and remains unresolved.
• An October 29 report revisited the review and NYSE compliance issue but did not establish either as the cause of the gain.
• The broader market and software sector are under pressure; no trading-activity data was available to explain the move.